We identify here the RhoC/ROCK pathway as a strong candidate for therapeutic targeting to reduce cancer metastasis, and indeed ROCK inhibitors have previously been shown to reduce experimental metastasis (Itoh et al., 1999). This evidence concerns the gene RHOC and cancer.